LegoChem Biosciences Total Debt vs. Revenue
| 141080 Stock | KRW 105,600 7,700 7.87% |
For LegoChem Biosciences profitability analysis, we use financial ratios and fundamental drivers that measure the ability of LegoChem Biosciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well LegoChem Biosciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between LegoChem Biosciences's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of LegoChem Biosciences over time as well as its relative position and ranking within its peers.
LegoChem |
LegoChem Biosciences Revenue vs. Total Debt Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining LegoChem Biosciences's current stock value. Our valuation model uses many indicators to compare LegoChem Biosciences value to that of its competitors to determine the firm's financial worth. LegoChem Biosciences is the top company in total debt category among its peers. It also is the top company in revenue category among its peers totaling about 3.42 of Revenue per Total Debt. Comparative valuation analysis is a catch-all model that can be used if you cannot value LegoChem Biosciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for LegoChem Biosciences' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.LegoChem Total Debt vs. Competition
LegoChem Biosciences is the top company in total debt category among its peers. Total debt of Health Care industry is presently estimated at about 86.84 Billion. LegoChem Biosciences retains roughly 9.41 Billion in total debt claiming about 11% of equities under Health Care industry.
LegoChem Revenue vs. Total Debt
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
LegoChem Biosciences |
| = | 9.41 B |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
LegoChem Biosciences |
| = | 32.16 B |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
LegoChem Revenue vs Competition
LegoChem Biosciences is the top company in revenue category among its peers. Market size based on revenue of Health Care industry is presently estimated at about 2.39 Trillion. LegoChem Biosciences claims roughly 32.16 Billion in revenue contributing just under 2% to equities under Health Care industry.
LegoChem Biosciences Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in LegoChem Biosciences, profitability is also one of the essential criteria for including it into their portfolios because, without profit, LegoChem Biosciences will eventually generate negative long term returns. The profitability progress is the general direction of LegoChem Biosciences' change in net profit over the period of time. It can combine multiple indicators of LegoChem Biosciences, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
LegoChem Biosciences, Inc. a biopharmaceutical company, focuses on the development of novel therapeutics utilizing its proprietary LegoChemistry medicinal drug discovery technology and ADC platform. LegoChem Biosciences, Inc. was founded in 2006 and is headquartered in Daejeon, South Korea. LegoChem Bio is traded on Korean Securities Dealers Automated Quotations in South Korea.
LegoChem Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on LegoChem Biosciences. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of LegoChem Biosciences position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the LegoChem Biosciences' important profitability drivers and their relationship over time.
Use LegoChem Biosciences in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if LegoChem Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in LegoChem Biosciences will appreciate offsetting losses from the drop in the long position's value.LegoChem Biosciences Pair Trading
LegoChem Biosciences Pair Trading Analysis
The ability to find closely correlated positions to LegoChem Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace LegoChem Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back LegoChem Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling LegoChem Biosciences to buy it.
The correlation of LegoChem Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as LegoChem Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if LegoChem Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for LegoChem Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your LegoChem Biosciences position
In addition to having LegoChem Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Aggressive Defence Thematic Idea Now
Aggressive Defence
Macroaxis small cap, aggressive-outlook picks designed for investors that are willing to accept higher levels of risk to hedge exposure to above-average market volatility. The Aggressive Defence theme has 50 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Aggressive Defence Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in LegoChem Stock
To fully project LegoChem Biosciences' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of LegoChem Biosciences at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include LegoChem Biosciences' income statement, its balance sheet, and the statement of cash flows.